Aviptadil Acetate Salt Formulation Guide Vip Analog
- Oxidation Control: Maintain dissolved oxygen between 0.05 ppm to 0.5 ppm to prevent Methionine degradation.
- Temperature Stability: Process solutions strictly within the 2-8°C range to ensure peptide integrity.
- Excipient Compatibility: Utilize disodium EDTA and polysorbate 80 for enhanced shelf-life and solubility.
Aviptadil, a synthetic Vasoactive intestinal peptide (VIP) analog, represents a critical Peptide hormone in modern therapeutic development. As a 28-amino acid residue molecule, it shares significant structural homology with endogenous VIP, offering potent immunomodulatory and vasodilatory properties. For formulation engineers and procurement specialists, understanding the chemical nuances of the Acetate salt form is essential for developing stable liquid pharmaceutical preparations, particularly for inhalation or parenteral administration. This Formulation guide outlines the technical requirements for handling this sensitive Pharmaceutical API to ensure optimal performance and regulatory compliance.
Solubility Profiles in Acetate Salt Form
The chemical structure of Aviptadil includes a methionine residue, which significantly influences its solubility and stability profile. In its acetate form, the compound exhibits high solubility in water and aqueous organic solvents, making it suitable for liquid formulations. However, this solubility comes with the risk of hydrolysis and oxidation if not managed correctly. The amphipathic character of the peptide requires careful pH adjustment, typically targeting a range around 5.7 using citric acid and trisodium citrate buffers. This buffering system not only maintains pH stability but also supports the physiological compatibility required for respiratory or injectable applications.
When sourcing high-purity Acetate salt, buyers should verify the certificate of analysis (COA) for specific impurity profiles, particularly related to oxidation products. The presence of the methionine side chain makes the molecule highly susceptible to oxidative stress, which can decrease biological activity. Therefore, the initial solubility testing must be conducted under inert atmospheres to establish accurate baseline data for downstream processing.
Stability During Pharmaceutical Processing
Oxidation is the primary degradation pathway for Aviptadil during production. Recent industry studies indicate that maintaining strict environmental controls is non-negotiable for achieving a High purity final product. The formation of Met(O) impurities must be kept within the range of 0.01% to 0.2% to meet performance benchmarks for clinical efficacy. To achieve this, the production process must adhere to the following critical parameters:
- Dissolved Oxygen Control: The amount of dissolved oxygen in the solution and water for injection must be maintained between 0.05 ppm to 0.5 ppm. This is typically achieved by sparging filtered nitrogen gas through the solution during mixing and filling.
- Temperature Management: The temperature of the solution and water must be maintained at 2-8°C throughout the entire production process. Deviations above this range can accelerate degradation kinetics.
- Nitrogen Blanketing: Filtered nitrogen gas should be applied to the headspace of production tanks and vials during filling and capping to prevent oxygen ingress.
These controls are vital for preventing the removal of electrons from the methionine residue, which leads to activity loss. A Global manufacturer with robust quality systems will provide batch data confirming that these parameters were met during synthesis and packaging.
Compatibility with Common Excipients
Formulating Aviptadil requires a strategic selection of excipients to enhance stability without interfering with biological activity. The following components are recognized as compatible and effective in stabilizing liquid formulations:
| Excipient Class | Specific Agent | Function |
|---|---|---|
| Chelating Agent | Disodium EDTA | Binds free metals to prevent catalytic oxidation reactions. |
| Surfactant | Polysorbate 80 | Prevents aggregation and adsorption to container surfaces. |
| Buffering Agent | Citric Acid / Trisodium Citrate | Maintains pH stability around 5.7. |
| Tonicity Adjuster | Sodium Chloride or Dextrose | Ensures isotonicity for parenteral or inhalation use. |
Disodium EDTA is particularly critical as it binds free metals in the solution, preventing them from catalyzing degradation reactions. Polysorbate 80 serves as an emulsifying agent that protects the peptide during agitation and filtration. It is important to note that while these excipients are standard, their grades must be suitable for parenteral use to avoid introducing new impurities. NINGBO INNO PHARMCHEM CO.,LTD. ensures that all bulk materials meet stringent specifications required for integration into these complex systems.
Commercial Supply and Quality Assurance
For large-scale production, securing a reliable supply chain is as important as the formulation chemistry itself. Partnering with a reputable Global manufacturer ensures consistent access to Research grade and GMP-compliant materials. Key considerations for procurement include verifying the COA for each batch, confirming the absence of heavy metals, and ensuring the Bulk price aligns with project budgets without compromising quality.
NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier provider of these technical advantages, offering bulk supply capabilities that support both clinical trials and commercial manufacturing. Their commitment to quality ensures that every batch of Aviptadil serves as a reliable Equivalent to established standards, facilitating smoother regulatory filings. By prioritizing High purity and technical support, manufacturers can mitigate the risks associated with peptide degradation and ensure the final VIP analog product delivers consistent therapeutic outcomes.
Conclusion
Successfully formulating Aviptadil requires a rigorous approach to oxidation control, temperature management, and excipient selection. By adhering to dissolved oxygen limits below 0.5 ppm and maintaining cold chain processing, formulators can minimize Met(O) impurities. Leveraging high-quality raw materials from trusted sources like NINGBO INNO PHARMCHEM CO.,LTD. further guarantees the integrity of the final Pharmaceutical API. This technical diligence ensures that the therapeutic potential of this powerful Peptide hormone is fully realized in clinical applications.